Trial intelligence / Profile preview

Effects of escitalopram on attention and cognitive functions in healthy volunteers

2005-001991-11Phase 4Completed

Sponsor
RWTH Aachen University
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of escitalopram (2 arms), sponsored by RWTH Aachen University. Primary endpoints: Number of subjects studied, Effects on attention and cognitive functions and 1 more. Started Oct 2005; status: completed.

02

Drugs

escitalopram

Beyond the preview

Go deeper on 2005-001991-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001991-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call